Top Stories
‘If I turn up on your doorstep you’re likely getting thousands -…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
Image source: Getty Images I’ve held Fundsmith Equity in my Stocks…
‘If I turn up on your doorstep you’re likely getting thousands…
LONDON – Alpha Real Trust Limited (ART) disclosed the outcome of…
Image source: Getty Images In late September, I bought some shares…
Investments
Though Trump is set to reshape the future of AI in America,…
Economy Insights
National News
In order to justify the effort of selecting individual stocks, it’s worth striving to beat the returns from a market index fund. But in any portfolio, there…
WEST PALM BEACH, Florida (Reuters) – President-elect Donald Trump headed to Washington on Saturday ahead of his inauguration on a U.S. military airplane supplied by U.S. President…
MOSCOW (Reuters) – Russian forces took control of two more settlements in eastern Ukraine’s Donetsk region, Russia’s Defence Ministry said on Saturday, the latest in a series…
By Jonathan Landay and Eric Cox WASHINGTON (Reuters) -President-elect Donald Trump’s administration will launch immigration sweeps in multiple U.S. cities almost as soon as he takes office…
The $112 million Mega Millions jackpot marks the largest win ever on a lottery courier app NEW YORK, Jan. 18, 2025 /PRNewswire/ — Just three weeks into…
New York, New York–(Newsfile Corp. – January 18, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims…